España
Italia
대한민국
日本
Français
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
Italia
대한민국
日本
Français
Login
Register
Premium Services
Financial News
Latest
Earnings
Guidance
Dividends
M&A
Buybacks
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Small-Cap
Markets
Pre-Market
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Markets
Pre-Market
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Recent
Markets
Baird Equity Research
Hibbett Analysts On Q2 Earnings: 'Back-To-School Off To Strong Start'
Why This Activision Blizzard Analyst Is Turning Bullish Ahead Of Microsoft Deal
Peloton's Worth A Ride, Baird Says In Bullish Initiation
Why This Activision Blizzard Analyst Is Turning Bullish Ahead Of Microsoft Deal
Peloton's Worth A Ride, Baird Says In Bullish Initiation
RingCentral Analysts Bullish On Company's Cloud Opportunity
Is Abercrombie & Fitch Back In Fashion With The Street?
RingCentral Analysts Bullish On Company's Cloud Opportunity
Is Abercrombie & Fitch Back In Fashion With The Street?
3 Texas Roadhouse Analysts Agree: Wait For A Better Entry Point In Stock
Baird Names Canada Goose A 'Fresh Pick' Ahead Of Q3 Print
Read More...
Baird Equity Research Recent News
Wall Street Remains Divided On Nike
Surface Oncology Offers 'Robust Pipeline,' Baird Says In Bullish Initiation
Once Again, Baird Predicts End To Tandem's 'Fantastic' Run
Tesla's Executive Turnover Doesn't Rattle This Bullish Analyst
Baird Downgrades Urban Outfitters On Valuation, Not Execution
The Pros And Cons From Twitter's Q2 Earnings Report
Baird Downgrades Express Scripts On Industry Instability
RH Surges 35% After Q1 Earnings: Here's What Wall Street Thinks
Adient's Turnaround Will Take Years, Baird Says In Bearish Turn
Baird Defends First Solar As 'Fresh Pick,' Finds Comfort In Revenue Visibility
Baird Still Buying Tesla After Shareholder Meeting, Calls Energy Opportunity Underappreciated
4 Apple Analysts Pick Apart WWDC Highlights
Construction Partners: Baird Sees Long-Term Investment Opportunity In Contractor's Stock
Take Advantage Of Cisco's Sell-Off, Baird Says
Baird: Mersana Is A Buy On Differentiated Platform For Cancer Indications
Chipotle's Q1: The Wall Street Reaction
Baird: Biogen A Buy On M&A Prospects, Underappreciated Franchises
NewLink Genetics' Potential Catalysts Not Enough To Justify A Bullish Stance, Baird Says In Downgrade
A Model 3 Miss, Capital Questions And Factory Shutdowns: What Wall Street Says About Tesla's Q1 Deliveries
The Early Reaction To Tesla's Q1 Production Numbers
Lululemon's Q4 Has The Sell Side Saying 'Namaste'
Tesla Should Exceed Low Production Bar; Analyst Says Buy On Pessimism
Baird: Will Data Scandal Impact Facebook Usage Metrics?
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started